搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
来自MSN
1 天
减肥药试验结果未达预期,诺和诺德市值“瘦身”4600亿元 分析师 ...
12月20日,诺和诺德公布的司美格鲁肽“升级版”药物CagriSema临床试验结果不及预期,导致公司美股开盘前一度跌近30%,收盘时下跌17.83%,市值蒸发625亿美元。此次三期临床试验针对超重或肥胖患者,CagriSema在68周后使患者体重减轻 ...
来自MSN
2 天
盘前大跌28%!诺和诺德司美格鲁肽升级版减重数据不及预期
诺和诺德公布了司美格鲁肽合剂产品的积极减重研究数据,但由于不及此前市场预期,美股盘前股价大跌,而其竞争对手美国礼来公司盘前上涨明显。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Commutes 37 sentences
MLB's stolen base king dies
US fighter jet shot down
Vows to rename Denali
Taxpayers to get up to $1,400
Sleeping woman set ablaze
'Die Hard 2' actor dies
Drops out of Senate race
Miller to join DOGE panel
Deputy defense secretary
Ambassador to Switzerland
Moore receives Bronze Star
Warns on Panama Canal
Top NYPD officer resigns
MO abortion ban blocked
Speeds to $62M debut
China: US ‘playing with fire'
Russian fuel depot targeted
More than 170 rescued
RFK Stadium bill passed
US ambassador to Italy
NE governor hospitalized
Special envoy to the UK
100 salmonella cases linked
Reverses Ohio layoffs
Brazil bus crash: 38 dead
Nic Claxton fined $25K
NBA fines Celtics coach
Proposes contract changes
Penn State wins eighth title
Starbucks strike expands
Team Langer wins in playoff
反馈